Filing Details
- Accession Number:
- 0001181431-11-000465
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-03 18:48:55
- Reporting Period:
- 2010-12-29
- Filing Date:
- 2011-01-03
- Accepted Time:
- 2011-01-03 18:48:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
811831 | Northeast Bancorp | NBN | State Commercial Banks (6022) | 010425066 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1319128 | S Claire Bean | C/O Northeast Bancorp 500 Canal Street Lewiston ME 04240 | Cfo And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Voting Common Stock | Acquisiton | 2010-12-29 | 71,788 | $13.93 | 71,788 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Voting Common Stock | Stock Option (Right to Buy) | Acquisiton | 2010-12-29 | 59,404 | $0.00 | 59,404 | $13.93 |
Voting Common Stock | Stock Option (Right to Buy) | Acquisiton | 2010-12-29 | 59,404 | $0.00 | 59,404 | $13.93 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
59,404 | 2020-12-29 | No | 4 | A | Direct | |
59,404 | 2020-12-29 | No | 4 | A | Direct |
Footnotes
- The stock option becomes exercisable in five equal annual installments, commencing on December 29, 2011.
- Each of these stock options shall become exercisable in three equal tranches based upon the price of the Company's Voting Common Stock exceeding the applicable hurdle price for at least 50 of the previous 75 consecutive trading days (such 50th day, the "Determination Date"), but only after and for so long as the most recent annual assessment of the Company's internal controls completed prior to the applicable Determination Date has concluded that the Company maintained effective internal control over financial reporting (subject to auditor verification, if applicable). The applicable hurdle price for the first tranche of exercisability is: prior to the fifth anniversary of the grant date, $27.86; between the fifth and sixth anniversaries of the grant date, $31.34; and between the sixth and seventh anniversaries of the grant date, $34.83. (Continued in footnote 3).
- The applicable hurdle price for the second tranche of exercisability is: prior to the sixth anniversary of the grant date, $31.34; and between the sixth and seventh anniversaries of the grant date, $34.83. The applicable hurdle price for the third tranche of exercisability is, prior to the seventh anniversary of the grant date, $34.83.